Milnacipran
SAVELLA is indicated for the management of fibromyalgia. SAVELLA is not approved for use in pediatric patients [see Use in Specific Populations ( 8.4 )] .
United States
$239
per month
India
$1
per month
You save
−99.43%save $237/mo · 99.43% cheaper
82.3K US scripts/yr$19.5M potential annual savings$19.7M US spend/yr
Drag to rotate · 3D structureC15H22N2O
SMILES: CCN(CC)C(=O)[C@@]1(C[C@@H]1CN)C2=CC=CC=C2
Compare the price
US price$239per month
India price$1per month
You save$23799.43% less
Based on 30 units per month. US $7.96 vs India $0.05 per unit.
Total over 1 periodSave $237$239 → $1
The bigger picture
Milnacipran is filled about 82.3K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$19.7M
If sourced from India
$111.1K
Potential annual savings
$19.5M
−99%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.